1. Economic Features of Antibiotic Resistance: The Case of Methicillin-Resistant Staphylococcus aureus

   • Fernando Antonanzas
   • Carmen Lozano
   • Carmen Torres

   Leading Article 02 December 2014 Pages: 285 - 325

2. Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis

   • Wei Zhang
   • Nazrul Islam
   • Aslam H. Anis

   Systematic Review 05 December 2014 Pages: 327 - 340

   

3. Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies

   • Huajie Jin
   • Paul McCrone

   Systematic Review 10 January 2015 Pages: 341 - 353

   

4. An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis

   • Rachael Maree Hunter
   • Gianluca Baio
   • Nick Freemantle

   Practical Application 17 January 2015 Pages: 355 - 366

   

5. Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada

   • Thomas E. Delea
   • Jordan Amdahl
   • Marroon Thabane

   Original Research Article 09 December 2014 Pages: 367 - 380

   

6. Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX^®) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

   • Rizwan Hamid
   • Clara Loveman
   • Dmitry Gultyaev

   Original Research Article Open access 20 December 2014 Pages: 381 - 393

   

7. Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control

   • Andrej Janzic
   • Mitja Kos

   Original Research Article 16 December 2014 Pages: 395 - 408

   

8. Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

   • Essè Ifèbi Hervé Akpo
   • Karin Cerri
   • Joris Kleintjens

   Original Research Article Open access 11 January 2015 Pages: 409 - 422